Our metabolic and transcriptomic analyses have allowed us to precisely map the extensive metabolic reprogramming that follows CDK4/6 depletion in HCT116 colorectal cancer cells, characterized by an increase in mitochondrial metabolism and function accompanied with an enhanced metabolism of glucose, glutamine and amino acids. The gene discussed is CDK4; the disease is colorectal cancer.